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ATR is a key regulator of checkpoint responses
to incompletely replicated and damaged DNA,
but the mechanisms underlying control of its ki-
nase activity are unknown. TopBP1, the verte-
brate homolog of yeast Cut5/Dbp11, has dual
roles in initiation of DNA replication and regula-
tion of checkpoint responses. We show that re-
combinant TopBP1 induces a large increase in
the kinase activity of both Xenopus and human
ATR. The ATR-activating domain resides in a
conserved segment of TopBP1 that is distinct
from its numerous BRCT repeats. The isolated
ATR-activating domain from TopBP1 induces
ectopic activation of ATR-dependent signaling
in both Xenopus egg extracts and human cells.
Furthermore, Xenopus egg extracts containing
a version of TopBP1 with an inactivating point
mutation in the ATR-activating domain are de-
fective in checkpoint regulation. These studies
establish that activation of ATR by TopBP1 is
a crucial step in the initiation of ATR-dependent
signaling processes.
INTRODUCTION
In eukaryotic cells, various checkpoint-control mecha-
nisms help to preserve the integrity of the genome (Nyberg
et al., 2002; Sancar et al., 2004). Components of these
regulatory systems monitor the genome for the presence
of damaged or incompletely replicated DNA. Upon detect-
ing key features associated with these DNA structures,
checkpoint systems mobilize enzymatic cascades that
regulate cell-cycle progression and other critical pro-
cesses. Members of the phosphoinositide kinase-related
family of protein kinases (PIKKs), such as ATM and ATR,
are key upstream regulators of checkpoint responses
(Abraham, 2001). ATM responds principally to the occur-
rence of double-stranded DNA breaks (DSBs) in the ge-
nome. ATR plays a distinct role in the detection of stalled
DNA replication forks, but it also participates in DNA dam-
age responses (Abraham, 2001; Bakkenist and Kastan,
2004).Significantly, ATM and ATR depend upon numerous
other proteins in order to phosphorylate their downstream
targets. For example, one important target of ATR is Chk1,
a checkpoint effector kinase that regulates key cell-cycle
enzymes such as Cdc25 andWee1 (Guo et al., 2000; Hek-
mat-Nejad et al., 2000; Liu et al., 2000; Zhao and Piwnica-
Worms, 2001). The ATR-dependent phosphorylation of
Chk1 requires ATRIP, a binding partner of ATR (Cortez
et al., 2001; Zou and Elledge, 2003; Ball et al., 2005; Falck
et al., 2005; Kimet al., 2005). In addition, the trimeric Rad9-
Hus1-Rad1 (9-1-1) clamp, which depends upon the clamp
loader Rad17-RFC for deposition onto recessed DNA
ends, is necessary for this process (Sancar et al., 2004).
Moreover, various checkpoint mediator proteins are cru-
cial for the ability of PIKKs to phosphorylate downstream
kinases (Nyberg et al., 2002; Sancar et al., 2004).
Checkpoint mediator proteins include Claspin and
certain proteins that possess BRCA1 carboxy-terminal
(BRCT) domains, such as 53BP1 (Kumagai and Dunphy,
2000; Canman, 2003; Chini and Chen, 2003). Biochemical
studies have indicated that Claspin directly facilitates the
phosphorylation of Chk1 by ATR (Kumagai et al., 2004).
However, accumulating evidence has suggested that the
term ‘‘mediator,’’ although useful, understates the com-
plexity of these proteins. For example, Claspin appears
to have additional roles in DNA replication and sensing of
replication forks (Lee et al., 2003; Lin et al., 2004; Lee
et al., 2005). Furthermore, 53BP1 recognizes two features
of modified histones, which suggests that its interaction
with chromatin is important for some facet of a DNA dam-
age response (see van Attikum and Gasser, 2005).
TopBP1 is another example of a BRCT-containing pro-
tein that has been implicated in genomic stability (Garcia
et al., 2005). It is well known that relatives of TopBP1 in fis-
sion yeast (Cut5) and budding yeast (Dbp11) play essential
roles in both initiation of DNA replication and checkpoint
regulation (Saka and Yanagida, 1993; Araki et al., 1995;
Garcia et al., 2005). Human TopBP1, which was discov-
ered in two-hybrid studies as a topoisomerase IIb binding
protein, has been reported to contain eight BRCT repeats
(Yamane et al., 1997). Like its yeast counterparts, verte-
brate TopBP1 has been implicated in both DNA replication
and checkpoint control (Makiniemi et al., 2001; Van Hatten
et al., 2002; Hashimoto and Takisawa, 2003; Parrilla-
Castellar and Karnitz, 2003; Yamane et al., 2003; Garcia
et al., 2005). Additionally, a Drosophila homolog calledCell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc. 943
Mus101 appears to possess similar functional properties
(Holway et al., 2005). In humans, there is evidence that
TopBP1 also participates in transcriptional regulation and
chromatin structure (Garcia et al., 2005). Although the nu-
merous BRCT repeats of TopBP1 could help to explain its
wide-ranging functions, it is not understood how TopBP1
participates in such diverse aspects of DNA metabolism.
We have been studying the checkpoint responses to in-
completely replicated and damaged DNA in Xenopus egg
extracts. In this system,XenopusATR (Xatr) carries out the
activating phosphorylation of XenopusChk1 (Xchk1) in re-
sponse to stalled DNA replication forks (Kumagai et al.,
1998; Guo et al., 2000; Hekmat-Nejad et al., 2000). These
components also participate in the detection of various
forms of damaged DNA (Kumagai et al., 1998; Lupardus
et al., 2002; Stokes et al., 2002). During these responses,
Xatr undergoes a substantial increase in kinase activity
(Guo et al., 2000; Kumagai et al., 2004). The mediator pro-
tein Claspin directly facilitates the phosphorylation of
Xchk1 by Xatr (Kumagai et al., 2004). In the egg-extract
system, Xenopus TopBP1 (XtopBP1), also known as
Xcut5 and Xmus101, has two overall functions. It is essen-
tial for the loading of Cdc45 onto origins of replication and
is thus necessary for the initiation of DNA replication (Van
Hatten et al., 2002; Hashimoto and Takisawa, 2003). In ad-
dition, it possesses a distinct function in controlling the ac-
tivation of Xchk1 (Parrilla-Castellar and Karnitz, 2003).
However, the exact role that XtopBP1 plays in this process
has been unclear.
In this report, we have investigated themolecular mech-
anism by which Xatr-Xatrip undergoes an increase in ki-
nase activity upon induction of checkpoint responses.
Our overall goal has been to understand how components
at stalled replication forks and sites of DNAdamagepartic-
ipate in the activation of Xatr-Xatrip in Xenopus egg ex-
tracts and, by extension, of ATR-ATRIP in human cells. In
searching for factors thatmight be involved in this process,
we have found that XtopBP1 serves as direct positive ef-
fector of Xatr by strongly stimulating its kinase activity.
Thesefindings indicate that interactionofXatrwithacritical
protein at replication forks and sites of DNA damage in-
duces its activation and thus provide a key insight into
how these DNA structures trigger checkpoint responses.
RESULTS
Recombinant XtopBP1 Induces a Large Increase
in the Kinase Activity of Xatr
We have previously shown that Xatr undergoes a substan-
tial increase in kinase activity in response to checkpoint-
inducing DNA templates in Xenopus egg extracts (Guo
et al., 2000; Kumagai et al., 2004). These observations
suggested that Xatr undergoes activation upon interaction
with DNA, a DNA-associating protein (or proteins), or both.
In assessing various plausible candidates for Xatr-activat-
ing factors, we considered the model wherein XtopBP1
might play a direct role in this process. To examine this
possibility, we first isolated Xatr from egg extracts by944 Cell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc.pull-downs with FLAG-tagged Xenopus ATRIP (Xatrip).
For these experiments, we used both full-length Xatrip
and an N-terminal truncation mutant (DN222) that sup-
ports normal Xatr-dependent activation of Xchk1 in egg
extracts (Kumagai et al., 2004; Kim et al., 2005). As shown
in Figure 1A, Xatr bound well to beads containing either
wild-type or DN222 Xatrip but not to control beads lacking
Xatrip. We eluted the beads with FLAG peptide and mixed
the eluates with a His6-tagged version of XtopBP1 that
had been purified from baculovirus-infected insect cells
(Figure 1B). Finally, we added [32P]ATP and PHAS-I,
a commonly used model substrate for ATR (Abraham,
2001). As shown in Figure 1C, addition of XtopBP1 in-
duced a very large increase in the kinase activity of both
Xatr-Xatrip complexes toward PHAS-I. The Xatr-Xatrip
preparations themselves exhibited relatively low kinase
activity under these conditions. In addition, the prepara-
tion of recombinant XtopBP1 alone contained negligible
kinase activity toward PHAS-I. In a dose-response analy-
sis, we observed that half-maximal induction of kinase
activity occurred at approximately 10–15 mg/ml XtopBP1
(Figures 1D and 1E). For comparison, the endogenous con-
centration of XtopBP1 in egg extracts is about 5 mg/ml
(Hashimoto and Takisawa, 2003).
In order to establish the specificity of our assay, we car-
ried out similar experiments with egg extracts lacking Xatr.
For this purpose, we removed Xatr from the extracts by
immunodepletion with anti-Xatr antibodies. In parallel,
we prepared mock-depleted extracts with control anti-
bodies. Next, we incubated recombinant XatripDN222-
FLAG in mock-depleted and Xatr-depleted extracts in
the presence of anti-FLAG beads. We reisolated the
beads, eluted with FLAG peptide, added His6-XtopBP1,
and assayed kinase activity toward PHAS-I. As expected,
Xatr was present in the preparation from mock-depleted
but not from Xatr-depleted extracts (Figure 2A). We ob-
served that His6-XtopBP1 could not elicit any kinase activ-
ity toward PHAS-I in the preparation from Xatr-depleted
extracts (Figures 2A and 2B). By contrast, consistent
with the results described above, His6-XtopBP1 induced
strong kinase activity in the preparation from mock-de-
pleted extracts. These findings indicate that the induced
kinase activity is due to Xatr.
We also characterized the sensitivity of the XtopBP1-
activated form of Xatr to caffeine, a documented inhibitor
of ATR in numerous organisms (Abraham, 2001). As
shown in Figures 2C and 2D, caffeine inhibited the acti-
vated form of Xatr very effectively, with half-maximal inhi-
bition occurring at approximately 0.4 mM. This concentra-
tion is comparable to that previously reported for inhibition
of both human and Xenopus ATR (Sarkaria et al., 1999;
Guo et al., 2000).
The Xatr-Activating Function of XtopBP1 Resides
in a Discrete C-Terminal Domain
Next, we performed structure-function studies in order to
identify which part of XtopBP1 is responsible for the acti-
vation of Xatr. For this purpose, we produced a series of
Figure 1. Recombinant XtopBP1 Induces Activation of the
Xatr-Xatrip Complex
(A) Isolation of Xatr-Xatrip complexes. Control buffer (lane 1), His6-Xa-
tripDN222-FLAG (lane 2), and full-length His6-Xatrip-FLAG (lane 3)
were added to egg extracts containing anti-FLAG antibody beads. Af-
ter incubation, the beads were reisolated, washed, and eluted with 3X-
FLAG peptide. The eluates were immunoblotted with anti-Xatr (top)
and anti-FLAG antibodies (bottom).
(B) Preparation of His6-XtopBP1. The protein was purified from Sf9
cells and stained with Coomassie blue.
(C) The kinase activity of isolated Xatr-Xatrip is greatly increased in the
presence of His6-XtopBP1. Control eluate (lanes 1 and 2) and eluates
containing either Xatr-XatripDN222 (lanes 3 and 4) or Xatr-Xatrip com-
plexes (lanes 5 and 6) from (A) were incubated in kinase buffer with
[32P]ATP and PHAS-I in the absence (lanes 1, 3, and 5) or presence
(lanes 2, 4, and 6) of His6-XtopBP1. Reactions were subjected to
SDS-PAGE. The gel was stained with Coomassie blue (top), and 32P in-
corporation into PHAS-I was detected by phosphorimaging (bottom).
(D) His6-XtopBP1 induces the kinase activity of Xatr in a dose-depen-
dent manner. Xatr-XatripDN222 (lanes 1–7) and control eluate (lane 8)
were incubated either without XtopBP1 (lane 1) or with differentoverlapping GST fusion proteins containing approxi-
mately 300–350 amino acids from XtopBP1. Both human
TopBP1 and XtopBP1 are relatively large proteins that
contain approximately 1500 amino acids. XtopBP1, like
human TopBP1, has been reported to contain eight
BRCT repeats (Yamane et al., 1997; Van Hatten et al.,
2002; Hashimoto and Takisawa, 2003). Four expression
constructs were designed to contain two adjoining
BRCT repeats each (e.g., residues 1–348, 333–646, 623–
984, and 1197–1513) as designated in Figure 3A. In addi-
tion, we also prepared a GST fusion protein containing
a conserved region between BRCT domains VI and VII
(residues 972–1279). Upon incubation with Xatr-Xatrip,
we observed that the 972–1279 peptide induced activa-
tion of Xatr as effectively as full-length XtopBP1
(Figure 3B). By contrast, none of the BRCT-containing fu-
sion proteins had any effect on the activity of Xatr. We also
found that a similar fragment of human TopBP1 (residues
978–1192) from between BRCT domains VI and VII like-
wise activated Xatr-Xatrip very effectively (Figure 3C).
Therefore, the ATR-activating function is conserved in
both Xenopus and human TopBP1.
In order to pursue these observations further, we pro-
duced a full-length version of XtopBP1 in which most of
the ATR-activating domain had been deleted (the D993–
1196mutant) (Figure 3D). In contrast to the full-length pro-
tein, the XtopBP1D993–1196 mutant protein displayed no
Xatr-activating capacity (Figure 3E). Therefore, a con-
served segment of XtopBP1 between BRCT domains VI
and VII appears to be both necessary and sufficient for ac-
tivation of Xatr.
XtopBP1 Increases theKinaseActivity of Xatr toward
Numerous Substrates but Has No Effect on Xatm
To extend our analyses, we also examined two docu-
mented physiological substrates of Xatr, namely Xenopus
Mcm2 (Xmcm2) and Xchk1 (Guo et al., 2000; Zhao and
Piwnica-Worms, 2001; Cortez et al., 2004; Yoo et al.,
2004). For Xmcm2, we used the GST-Xmcm2(62–122) fu-
sion peptide, in which S92 is a target for Xatr (Yoo et al.,
2004). In thecaseofXchk1,weusedboth thewholeprotein
(Xchk1-Myc-His6) and a GST fusion peptide from its regu-
latory domain (residues 306–352) that contains S344, the
major phosphorylation site for Xatr (Guo et al., 2000; Liu
et al., 2000). For these experiments, we used the GST-
XtopBP1(972–1279) fragment as the activator of Xatr. We
found that the XtopBP1 fragment induced a strong Xatr-
dependent phosphorylation of the GST-Xmcm2(62–122)
peptide (see Figure S1 in the Supplemental Data available
with this article online). This phosphorylation occurred on
S92 because there was no 32P incorporation into the
S92A mutant of this peptide. Similarly, we observed that
the XtopBP1 fragment readily induced phosphorylation
amounts of XtopBP1 (0.5–30 mg/ml) (lanes 2–8) in the presence of
[32P]ATP andPHAS-I. Reactionswere processed for stainingwith Coo-
massie blue (top) and phosphorimaging (bottom).
(E) Quantitation of 32P incorporation into PHAS-I from (D).Cell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc. 945
Figure 2. The XtopBP1-Induced Kinase Activity of the Xatr-
XatripDN222-FLAG Complex Is Due to Xatr
(A) Egg extracts were left untreated (lanes 1–4) or subjected to an im-
munodepletion procedure with either control (lane 5) or anti-Xatr anti-
bodies (lane 6). Extracts were incubated with anti-FLAG beads in the
absence (lanes 1 and 2) or presence (lanes 3–6) of XatripDN222-
FLAG. The beads were reisolated and eluted with 3X-FLAG peptide.
Eluates were incubated with [32P]ATP and PHAS-I in the absence
(lanes 1 and 3) or presence (lanes 2 and 4–6) of His6-XtopBP1. After
SDS-PAGE, the top portion of the gel was immunoblotted with anti-
Xatr and anti-FLAG antibodies (top two panels). The bottom portion
was stained with Coomassie blue (second panel from bottom) and an-
alyzed with a phosphorimager (bottom panel).
(B) Quantitation of the data in (A). Data are represented asmean ± stan-
dard deviation.946 Cell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc.of both the GST-Xchk1(306–352) peptide and full-length
Xchk1-Myc-His6 on S344 (Figure S1). These experiments
establish that XtopBP1 strongly stimulates the ability of
Xatr to phosphorylate a variety of different substrates. Fur-
thermore, our results imply that the increased phosphory-
lation is due to elevated kinase activity rather than
XtopBP1-mediated tethering of Xatr to substrates be-
causewe have observed this effect with twodifferent small
peptides approximately 50–60 residues in length aswell as
a model substrate protein (PHAS-I). It seems implausible
that all of these substrates could be using XtopBP1 as an
adaptor protein. However, our observations do not rule
out the possibility that TopBP1 could play an additional
role in recognition of intact physiological substrates apart
from the process that we have characterized in this paper.
As another means to examine the specificity of this ac-
tivation process, we asked whether it occurred with an-
other member of the PIKK family. For this question, we im-
munoprecipitated both Xatr and Xatm in parallel from
Xenopus egg extracts and then incubated the immuno-
precipitates with GST-XtopBP1(972–1279) (Figure 3F).
Consistent with the results described above, we observed
strong activation of immunoprecipitated Xatr by this
method. By contrast, there was no activation of Xatm in
the presence of the GST-XtopBP1(972–1279) peptide.
Therefore, TopBP1 appears to be a specific activator of
ATR and not a general activator of the PIKK family.
XtopBP1 Associates with Xatr in a Manner
that Depends upon Xatrip
In order to explore the mechanism by which XtopBP1 ac-
tivates Xatr, we asked whether the two proteins could
associate physically with one another. For this question,
we incubated glutathione beads containing GST-XtopBP1
(972–1279) in egg extracts, reisolated the beads, and per-
formed immunoblotting for both Xatr and Xatrip. As shown
in Figure 4A, we could clearly detect binding of both Xatr
and Xatrip to beads containing GST-XtopBP1(972–1279).
Conversely, there was no binding of Xatr or Xatrip to gluta-
thione beads containing either noGST fusion protein or the
GST-XtopBP1(1197–1513) fragment,which is incapable of
activating Xatr. In addition, in other experiments, therewas
no binding of Xatr or Xatrip to beads containing GST fu-
sions of the 1–348, 333–646, or 623–984 segments from
XtopBP1 (data not shown).
We also asked whether the association of XtopBP1 with
Xatr depends upon Xatrip. For this experiment, we re-
moved endogenous Xatrip from egg extracts by immuno-
depletion with anti-Xatrip antibodies. As described previ-
ously, this procedure leaves behind approximately 30%
of theendogenousXatr, the fraction that is not in a complex
(C) Kinase activity of the activated form of Xatr is sensitive to caffeine.
Xatr-XatripDN222 was activated by His6-XtopBP1 and assayed for
kinase activity toward PHAS-I in the absence (lane 1) or presence of
0.04, 0.2, 1, and 5 mM caffeine (lanes 2–5) as in (A).
(D) Plot of the data in (C). Data are represented asmean ± standard de-
viation.
Figure 3. Mapping of the ATR-Activating Domain from XtopBP1
(A) Domains of XtopBP1. Roman numerals indicate BRCT domains, as designated in the literature. Fragments containing the indicated amino acids of
XtopBP1 (1–348, 333–646, 623–984, 972–1279, and 1197–1513) were produced as GST fusion proteins in bacteria. The D993–1196 mutant was pro-
duced as a His6 fusion in Sf9 cells.
(B) Xatr-XatripDN222 complex (lanes 1–6) and control eluate (lane 7) were incubated in the absence (lane 1) or presence (lanes 2–6) of GST fusion
proteins containing the indicated segments of XtopBP1 at a final concentration of 40 mg/ml in kinase buffer containing [32P]ATP and PHAS-I. Reac-
tions were subjected to SDS-PAGE. GST fusion proteins and PHAS-I were stained with Coomassie blue (top andmiddle panels). Incorporation of 32P
into PHAS-I was detected by phosphorimaging (bottom panel).
(C) The ATR-activating function is conserved in human TopBP1. The Xatr-XatripDN222 complex (lanes 1–3) was incubated with buffer alone (lane 1),
XtopBP1(972–1279) (lane 2), or human GST-TopBP1(978–1192) (lane 3) and assayed for kinase activity toward PHAS-I.
(D) Preparations of His6-XtopBP1 and His6-XtopBP1D993–1196 from Sf9 cells (stained with Coomassie blue).
(E) Control eluate (lanes 1–3) and Xatr-XatripDN222 complex (lanes 4–6) were incubated with buffer alone (lanes 1 and 4), full-length His6-XtopBP1
(lanes 2 and 5), or His6-XtopBP1D993–1196 (lanes 3 and 6) and assayed for kinase activity toward PHAS-I.
(F) XtopBP1 activates Xatr but not Xatm. Egg extracts were immunoprecipitated with control (lanes 1 and 2), anti-Xatr antibodies (lanes 3 and 4), or
anti-Xatm antibodies (lanes 5 and 6). The immunoprecipitates were incubated in the absence (lanes 1, 3, and 5) or presence (lanes 2, 4, and 6) of GST-
XtopBP1(972–1279) in kinase buffer containing [32P]ATP and PHAS-I. The samples were subjected SDS-PAGE and immunoblotted with anti-Xatm
(top) and anti-Xatr antibodies (middle). Kinase activity was determined by 32P incorporation into PHAS-I (bottom).Cell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc. 947
Figure 4. XtopBP1 Associates with Xatr in a Manner that De-
pends on Xatrip
(A) GST-XtopBP1(972–1279) associates with Xatr-Xatrip. Egg extracts
(lane 1) were incubated with no recombinant protein (lane 2), GST-
XtopBP1(972–1279) (lane 3), or GST-XtopBP1(1197–1513) (lane 4).
The extracts were filtered through a G25 Sephadex column to remove
endogenous glutathione and were incubated with glutathione-agarose
beads. The beads were isolated and immunoblotted for Xatr (top) and
Xatrip (bottom).
(B) Egg extracts (lane 1) were immunodepleted with control (lane 2) or
anti-Xatrip antibodies (lanes 3 and 4). For lane 4, recombinant Xa-
tripDN222-FLAG was added back later. Extracts were immunoblotted
with anti-Xatr (top) and anti-Xatrip antibodies (bottom).
(C) Control buffer (lane 1) and GST-XtopBP1(972–1279) (lanes 2–4)
were incubated with the indicated extracts from (B). Binding of Xatr
to glutathione beads was determined by immunoblotting as in (A).948 Cell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc.with Xatrip (Kumagai et al., 2004). Next, we added GST-
XtopBP1(972–1279) to the Xatrip-depleted extracts and
to mock-depleted extracts that had been prepared in par-
allel. As shown in Figures 4Band4C,weobserved nobind-
ing of Xatr to the XtopBP1 fragment in Xatrip-depleted ex-
tracts, whereas there was good binding in mock-depleted
extracts. Furthermore, we could restore the binding of Xatr
to the XtopBP1 fragment by addition of recombinant Xa-
tripDN222-FLAG to the Xatrip-depleted extracts. These
results indicate that XtopBP1 depends upon the presence
of Xatrip in order to associate with Xatr-Xatrip.
To pursue this observation further, we asked whether
activation of Xatr by XtopBP1 depends on Xatrip. As
shown in Figure 4D, treatment with XtopBP1 could not sig-
nificantly increase the kinase activity of Xatr that had been
immunoprecipitated from Xatrip-depleted extracts. Nota-
bly, it has been established that binding of ATRIP to ATR is
necessary for checkpoint-dependent phosphorylation of
Chk1 in both human cells and Xenopus egg extracts (Falck
et al., 2005; Kim et al., 2005). In principle, this observation
could be explained by a failure of TopBP1 to activate ATR
in the absence of ATRIP.
Identification of a Point Mutant of XtopBP1
that Is Defective for Activation of Xatr
As shown in Figure 5A, the ATR-activating domain of
XtopBP1 is well conserved in other vertebrates, including
humans, chickens, and zebrafish. In order to explorewhich
aspects of this region were important for the activation of
Xatr, we first prepared some deletions of highly conserved
segments (e.g., RQLQ and WDDP) in the context of the
GST-XtopBP1(972–1279) fragment. We found that the
DRQLQmutant was very strongly compromised in its abil-
ity to induce the activation of Xatr, while the DWDDP mu-
tantwas virtually inactive (Figure 5B). To pursue these find-
ings further, we generated a point mutant (W1138R) in
which the tryptophan in the WDDP motif was changed to
arginine. We observed that W1138R mutant of GST-
XtopBP1(972–1279) had totally lost its capacity to induce
the activation of Xatr (Figure 5B). Interestingly, however,
the W1138R mutant retains significant ability to bind
Xatr-Xatrip (Figure S2).
TopBP1 Induces Activation of Wild-Type but Not
Kinase-Deficient Recombinant Human ATR
In order to address the generality of these findings, we
asked whether TopBP1 could also induce activation of
recombinant human ATR. Accordingly, we isolated wild-
type and kinase-deficient versions of FLAG-tagged human
ATR from nuclear extracts of U2OS cells that conditionally
(D) Xatr was immunoprecipitated from mock-depleted (lanes 1 and 2)
and Xatrip-depleted extracts (lanes 3 and 4). We immunoprecipitated
twice as much Xatrip-depleted extract due to its reduced content of
Xatr. The immunoprecipitates were incubated with control buffer
(lanes 1 and 3) or GST-XtopBP1(972–1279) (lanes 2 and 4) and as-
sayed for kinase activity toward PHAS-I (bottom). Samples were also
immunoblotted for Xatr (top) and Xatrip (middle).
Figure 5. Identification of a Point Mutant in the ATR-Activating Domain and Activation of Recombinant Human ATR
(A) Alignment of residues 993–1196 from the ATR-activating domain of XtopBP1 with corresponding segments of human, chicken, and zebrafish
TopBP1. Two conserved sequences (RQLQ and WDDP) are marked with lines, and a conserved tryptophan (W1138 in XtopBP1) is denoted with
an asterisk.
(B) Xatr-XatripDN222was incubated with GST-XtopBP1(1197–1513) (lane 1) or wild-type (lane 2), W1138R (lane 3),DWDDP (lane 4), andDRQLQ (lane
5) versions of GST-XtopBP1(972–1279) in the presence of PHAS-I and [32P]ATP. Reactions were stained with Coomassie blue to detect GST fusions
(top) and PHAS-I (middle) and were analyzed with a phosphorimager (bottom).
(C) Isolation of recombinant human ATR proteins. Protein G magnetic beads containing no antibody (lane 1) or anti-FLAG antibodies (lanes 2 and 3)
were incubated in nuclear extracts of theGW33 andGK41U2OS cell lines that were induced to express either wild-type (WT) (lanes 1 and 2) or kinase-
deficient (KD) FLAG-ATR (lane 3), respectively. The beads were reisolated and eluted with 3X-FLAG peptide. The whole preparations (beads plus
eluates) were immunoblotted with anti-FLAG antibodies.
(D) Activation of recombinant human ATR.Mock preparations (lanes 1–3) and preparations containing eitherWT (lanes 4–6) or KD FLAG-ATR (lanes 7–
9) from (C) were incubated with control buffer (lanes 1, 4, and 7), GST-XtopBP1(972–1279) (lanes 2, 5, and 8), or GST-XtopBP1(972–1279)-W1138R
(lanes 3, 6, and 9) in the presence of GST-Xmcm2(62–122). Samples were subjected to SDS-PAGE and processed for staining with Coomassie blue
(top) and immunoblotting with anti-phospho-S92 of Xmcm2 antibodies (bottom).express these proteins (Figure 5C). The recombinant ATR
proteins were purified with anti-FLAG magnetic beads
under conditions that preserve the binding of endogenous
ATRIP (U¨nsal-Kac¸maz and Sancar, 2004). Next, we incu-
bated both the wild-type and kinase-deficient FLAG-ATR
preparations in the absence or presence of GST-
XtopBP1(972–1279) and measured kinase activity against
S92 of the GST-Xmcm2(62–122) peptide. We also tested
the inactive W1138R mutant of the XtopBP1 fragment.
As depicted in Figure 5D, GST-XtopBP1(972–1279) in-
duced a large increase in the kinase activity of wild-type
FLAG-ATR. By contrast, the W1138R mutant did not
induce any activation ofwild-type ATR. As another control,
we also showed that GST-XtopBP1(972–1279) did not
induce any kinase activity in a mock preparation of mag-
netic beads (lacking anti-FLAG antibodies) that was
prepared from cells expressing wild-type FLAG-ATR.
Finally, under the same assay conditions, we found that
neither the intact nor W1138R mutant form of GST-XtopBP1(972–1279) had any effect on the activity of ki-
nase-deficient FLAG-ATR (Figure 5D). These results es-
tablish that TopBP1can activate bothXenopus andhuman
ATR. Furthermore, these experiments provide conclusive
evidence that the kinase activity that is inducedbyTopBP1
is intrinsic to theATRprotein itself and is not due to akinase
that associates with ATR.
The ATR-Activating Domain of TopBP1 Can
Trigger Ectopic Phosphorylation
of Downstream Targets of ATR
Because the GST-XtopBP1(972–1279) fragment could
activate Xatr in vitro without the inclusion of DNA, we rea-
soned that ectopic addition of this fragment to Xenopus
egg extracts might also be able to trigger the Xatr-depen-
dent phosphorylation of Xchk1 even in the absence of
a checkpoint-inducing DNA template. To explore this
possibility, we incubated egg extracts with increasing
amounts of GST-XtopBP1(972–1279) in the presence ofCell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc. 949
Figure 6. The Isolated ATR-Activating Domain of TopB1 Induces Ectopic Phosphorylation of Downstream Targets of ATR
(A) Control buffer (lane 1), GST-XtopBP1(972–1279) at a final concentration of either 50 mg/ml (lane 2) or 100 mg/ml (lane 3), and 100 mg/ml GST-
XtopBP1(1197–1513) (lane 4) were added to interphase egg extracts. Extracts were incubated for 90 min in the presence of 35S-Xchk1 and 3 mM tau-
tomycin. Reactions were subjected to SDS-PAGE and phosphorimaging.950 Cell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc.
35S-labeled Xchk1 and tautomycin (to inhibit cytoplasmic
phosphatases) (Kumagai and Dunphy, 2000). As shown in
Figure 6A, the 972–1279 fragment could elicit a very ro-
bust phosphorylation of Xchk1, as indicated by a decrease
in electrophoretic mobility. By contrast, the GST-XtopBP1
(1197–1513) fragment, which does not activate Xatr, did
not induce any phosphorylation of Xchk1 in egg extracts.
Furthermore, none of the DRQLQ, DWDDP, or W1138R
mutants of the 972–1279 fragment could induce ectopic
activation of Xchk1 in these extracts (Figure 6B).
To pursue this issue further, we asked whether the ATR-
activating domain of TopBP1 could induce ATR-depen-
dent phosphorylation in human cells. For this purpose,
we constructed a version of the enhanced green fluores-
cent protein (EGFP) containing the SV40 nuclear localiza-
tion sequence and residues 978–1286 of human TopBP1
(equivalent to residues 972–1279 of XtopBP1). We also
produced the W1145R mutant of this plasmid (analogous
to the W1138R mutant of XtopBP1). We transfected plas-
mids encoding these proteins into human 293T cells and
performed immunoblotting with anti-phosphopeptide an-
tibodies that detect phosphorylation of human Mcm2 on
S108 (which corresponds to S92 of Xmcm2) (Cortez
et al., 2004; Yoo et al., 2004). As shown in Figure 6C, cells
expressing the wild-type 978–1286 fragment of human
TopBP1 displayed significantly elevated phosphorylation
of Mcm2 on S108, whereas there was no effect on cells
expressing EGFP alone or theW1145Rmutant. Moreover,
we also observed an increase in the phosphorylation of
S108 in the presence of the 978–1286 human fragment
by using indirect immunofluorescence (Figures 6D and
6E). Therefore, the ATR-activating domain of human
TopBP1 can induce ATR-dependent phosphorylation of
a downstream target in a human cell line in the absence
of any DNA replication inhibitor or damaging agent.
An Intact ATR-Activating Domain Is Necessary for
XtopBP1 to Support Checkpoint-Dependent
Phosphorylation of Xchk1 in Egg Extracts
Finally,weaskedwhether XtopBP1must possessan intact
ATR-activating domain for Xenopus egg extracts to dis-
play a normal checkpoint response to stalled DNA replica-
tion forks. For this purpose, we first produced a version of
full-length His6-XtopBP1 with the W1138R mutation,
which we demonstrated is also unable to activate Xatr
(Figures 7A and 7B). We proceeded to remove endoge-
nous XtopBP1 from egg extracts by immunodepletionwith anti-XtopBP1 antibodies (Figure 7C). In parallel, we
usedcontrol antibodies topreparemock-depletedextract.
Next, we added back wild-type His6-XtopBP1 or the His6-
XtopBP1-W1138R mutant to aliquots of the XtopBP1-
depleted extract. Finally, we added aphidicolin and
demembranated Xenopus sperm nuclei to the various
extracts in order to create stalled replication forks and
then examinedphosphorylation of Xchk1 (Figure 7D). Con-
sistentwithprevious studies, thephosphorylationof Xchk1
was abolished in the absence of XtopBP1 (Parrilla-Castel-
lar and Karnitz, 2003). As anticipated, addition of wild-type
His6-XtopBP1 to the XtopBP1-depleted extract was able
to rescue the phosphorylation of Xchk1 fully. By contrast,
we found that the W1138R mutant could not restore the
phosphorylation of Xchk1.
In conjunction with these experiments, we also exam-
ined chromosomal DNA replication in extracts containing
either wild-type or W1138R His6-XtopBP1. As shown in
Figure 7E, DNA replication was not inhibited in extracts
containing the W1138R mutant. Therefore, the defect in
phosphorylation of Xchk1 in the extracts containing this
mutant is not due to a failure in the assembly of DNA rep-
lication forks. Taken together, these results indicate that
XtopBP1must have an intact ATR-activating domain in or-
der to support the Xatr-dependent phosphorylation of
Xchk1 that normally occurs in the presence of stalled
DNA replication forks.
DISCUSSION
ATR is a pivotal upstream regulator of checkpoint re-
sponses to incompletely replicated and damaged DNA.
Although knowledge is accumulating steadily about ATR-
mediated processes, the regulation of ATR itself has
been somewhat enigmatic. We have shown previously
that Xatr undergoes an increase in kinase activity during
a checkpoint response in Xenopus egg extracts (Guo
et al., 2000; Kumagai et al., 2004). On the other hand, it
has not heretofore been possible to detect an activated
form of mammalian ATR (discussed in Abraham, 2001;
Bakkenist and Kastan, 2004).
In this report, we have shown that recombinant TopBP1
induces a large increase in the activity of Xatr toward
a number of different substrates. We have also observed
a similar activation of wild-type but not kinase-deficient
recombinant human ATR. Therefore, the TopBP1-depen-
dent activation of ATR is a conserved property of this(B) Phosphorylation of [35S]Xchk1was determined in egg extracts that were incubatedwith control buffer (lane 1), GST-XtopBP1(972–1279) (lane 2), or
the indicatedmutants of the 972–1279 fragment (lanes 3–5) as described in (A). All GST fusion proteinswere added at a final concentration of 100mg/ml.
(C) Human 293T cells were transfected with plasmids encoding EGFP (lane 1), wild-type EGFP-NLS-TopBP1(978–1286) (lane 2), and EGFP-NLS-
TopBP1(978–1286)-W1145R (lane 3). In addition, untransfected cells were incubated in the absence (lane 4) or presence of 2 mM hydroxyurea for
18 hr (lane 5). Lysates from the cells were immunoblotted with antibodies against phospho-S108 of humanMcm2 (top) or the Mcm2 protein (bottom).
(D) 293Tcellswere transfectedwith the indicatedplasmids.Cellswereprocessed for indirect immunofluorescencewith anti-phospho-S108antibodies
and Alexa 568-conjugated goat anti-rabbit antibodies. In addition, cells were examined for fluorescence of EGFP and stained for DNA with Hoechst
33258.
(E)Quantitation (with the ImageJprogram) of the immunofluorescence signal of phospho-S108 from thecells in (D) aswell as fromcells transfectedwith
EGFP alone. Signals were compared between expressing and nonexpressing cells. Data are represented as mean ± standard deviation.Cell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc. 951
Figure 7. The W1138R Mutant of XtopBP1 Is Defective in Checkpoint Regulation in Xenopus Egg Extracts
(A) Preparations of wild-type (lane 1) and W1138R mutant (lane 2) versions of full-length His6-XtopBP1 were stained with Coomassie blue.
(B) Kinase reactions with control buffer (lane 1), wild-type His6-XtopBP1 (lanes 2 and 4), and His6-XtopBP1-W1138R (lanes 3 and 5) were conducted
with PHAS-I and [32P]ATP in the presence (lanes 1-3) or absence (lanes 4 and 5) of the Xatr-XatripDN222 complex. Samples were stained with Coo-
massie blue (top) or analyzed with a phosphorimager (bottom).
(C) ImmunodepletionofXtopBP1.Eggextractswere left untreated (lane1) or immunodepletedwithcontrol (lane2) or anti-XtopBP1antibodies (lanes3–5).
In some cases, either wild-type (lane 4) or W1138R His6-XtopBP1 (lane 5) was added back to the extracts. Extracts were immunoblotted for XtopBP1.
(D)Untreated (lanes1and2),mock-depleted (lane3), andXtopBP1-depletedextractscontainingcontrol buffer (lane4),wild-typeHis6-XtopBP1 (lane5), or
W1138RHis6-XtopBP1 (lane 6)were incubatedwith [
35S]Xchk1 in the absence (lane 1) or presence (lanes 2–6) of aphidicolin. Nuclear fractions were sub-
jected to SDS-PAGE and immunoblottedwith anti-phospho-S344 of Xchk1 antibodies (top). Samples were also analyzed by phosphorimaging (bottom).
(E) DNA replication wasmeasured in a 2 hr incubation by incorporation of 32P into chromosomal DNA in XtopBP1-depleted extracts to which either wild-
type (lane 1) or W1138R His6-XtopBP1 (lane 2) had been added back.kinase in vertebrates. The kinase-activating function of
TopBP1 resides within a discrete region of the protein
(the ATR-activating domain) that is clearly distinct from
its numerous BRCT repeats. Furthermore, we have identi-
fied a single inactivating point mutation in this domain
(W1138R) that abrogates both the in vitro Xatr-activating
function of XtopBP1 and its ability to support the Xatr-de-
pendent phosphorylation of Xchk1 in aphidicolin-treated
Xenopus egg extracts. Thus, we can link the in vitro bio-
chemical function of this domain as a kinase activator to
its role in checkpoint signaling in the egg-extract system.
Overall, these experiments provide compelling evidence
that TopBP1 activates ATR and, furthermore, that this ac-
tivation is necessary for ATR-mediated checkpoint signal-
ing in vertebrates. The ATR-activating domain is not obvi-
ously conserved inCut5 fromfission yeast andDbp11 from
budding yeast. It is possible that activation of ATR occurs
by a different mechanism in yeast or, alternatively, that
a putative ATR-activating region in the yeast proteins can-
not be discerned easily by sequence comparisons.952 Cell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc.Recent studies have indicated that activation of human
ATM involves dissociation of inactive dimers into mono-
mers and autophosphorylation of S1981 (Bakkenist and
Kastan, 2003). In addition, interaction with the Mre11-
Rad50-Nbs1 complex has been implicated in the activa-
tion of ATM (Lee and Paull, 2005). We have not observed
any obvious change in the incorporation of 32P into either
Xatr or Xatrip upon incubation with XtopBP1 (data not
shown), although we cannot eliminate the possibility that
some alteration has escaped our notice. Furthermore,
existing data suggest that neither human ATR-ATRIP nor
Xatr-Xatrip undergo a detectable change in oligomeric
status upon induction of a checkpoint response (U¨nsal-
Kac¸maz and Sancar, 2004; Ball and Cortez, 2005; Itakura
et al., 2005; Kim et al., 2005). Overall, the available infor-
mation suggests that there are significant mechanistic dif-
ferences between the activation of ATM and ATR.
The ATR-activating domain of XtopBP1 associates
physically with the Xatr-Xatrip complex in a manner that
depends upon Xatrip. We suspect that XtopBP1 induces
a conformational change in the Xatr-Xatrip complex that
increases its kinase activity. A general analogy would be
the activation of cyclin-dependent kinases (Cdks) by bind-
ing of cyclins (Morgan, 1997). A crucial difference, how-
ever, is that XtopBP1 appears not to form a tight persistent
complex with Xatr-Xatrip. We have observed that His6-
XtopBP1 separates from Xatr-Xatrip upon gel filtration in
a Superdex 200 column (data not shown). As a result, the
activity of Xatr-Xatrip reverts to its initial low level. Signifi-
cantly, this process is fully reversible in that addition of
His6-XtopBP1 to the appropriate column fractions con-
taining Xatr-Xatrip results in reactivation of Xatr (data not
shown). The relatively transient nature of this interaction
might explain why it has not been possible to detect an ac-
tivated form of ATR-ATRIP following extraction and immu-
noprecipitation from mammalian cells that have received
checkpoint-inducing treatments. It may simply be the
case that these procedures dislodge TopBP1 from ATR-
ATRIP and thereby inactivate ATR. The nature of the inter-
action between TopBP1 and ATR-ATRIP would allow ATR
to undergo activation in a very dynamic manner at DNA
replication forks and sites of DNA damage. This feature
may be important for ATR to function effectively at struc-
tures such as replication forks that characteristically form
and then disappear quite rapidly throughout the genome.
It has been established that TopBP1 localizes to sites of
replicative stress and DNA damage in human cells (Honda
et al., 2002; Yamane et al., 2002), and both TopBP1 and
ATR display colocalization at DSBs in mouse meiotic
chromosomes (Perera et al., 2004). Furthermore, XtopBP1
accumulates on etoposide-treated chromatin in Xenopus
egg extracts (Parrilla-Castellar and Karnitz, 2003). These
observations support the possibility that TopBP1 acti-
vates ATR-ATRIP in the locale of checkpoint-inducing
DNA structures. Therefore, an important question involves
the issue of how TopBP1 recognizes incompletely repli-
cated and damaged chromatin. In Xenopus egg extracts,
initial binding of XtopBP1 to chromatin does not require ei-
ther the prereplication complex or S phase Cdk activity
(Van Hatten et al., 2002; Hashimoto and Takisawa,
2003). After assembly of the prereplication complex, the
loading of Cdc45 and RPA onto sites of DNA replication
requires both XtopBP1 and Cdk activity (Van Hatten
et al., 2002; Hashimoto and Takisawa, 2003). Thereafter,
XtopBP1 associates with chromatin in much larger
amounts in a Cdk-dependent manner. It has been postu-
lated that the early Cdk-independent binding of XtopBP1
to chromatin has a role in initiation of replication, whereas
the Cdk-dependent mode of binding may be involved in
checkpoint regulation (Hashimoto and Takisawa, 2003).
Intriguingly, human TopBP1 has been shown to bind di-
rectly DNA in vitro, but the physiological function of this
binding is unknown (Yamane and Tsuruo, 1999).
Studies with simple homopolymeric DNA templates in
Xenopus egg extracts have indicated that single-stranded
DNA alone is not sufficient to induce either the Xatr-
dependent phosphorylation of Xchk1 or the activation of
Xatr-Xatrip (Kumagai and Dunphy, 2000; Lee et al.,2003; Kumagai et al., 2004). By contrast, certain annealed
complementary homopolymers (that would contain
stretches of both single-stranded and double-stranded
DNA) are very effective at triggering both the activation
of Xatr-Xatrip and subsequent phosphorylation of Xchk1
(Kumagai and Dunphy, 2000; Lee et al., 2003; Kumagai
et al., 2004). The recessed DNA ends in these templates
would resemble primer-template junctions at DNA replica-
tion forks, which have been proposed as checkpoint-trig-
gering signals (Michael et al., 2000; You et al., 2002).
The formation of RPA-coated single-stranded DNA in
chromatin is required for the initiation of ATR-mediated
checkpoint signaling (Costanzo et al., 2003; Zou and
Elledge, 2003; Byun et al., 2005). However, human ATR-
ATRIP and Xatr-Xatrip do not need to associate stably
with RPA-coated DNA in order to carry out the activation
of Chk1 (Ball et al., 2005; Kim et al., 2005). Furthermore,
removal of RPA from Xenopus egg extracts does not in-
hibit the Xatr-dependent phosphorylation of Xchk1 in re-
sponse to the simple double-stranded DNA templates de-
scribed above (Kim et al., 2005). The implication is that,
although RPA is required for the formation of check-
point-inducing DNA structures within chromatin, some
distinct factor carries out the actual activation of ATR.
Moreover, this process of activation would depend upon
the presence of DNA with some double-stranded charac-
ter (primed DNA at replication forks and recessed DNA
ends at sites of damage). The findings in this paper indi-
cate that this activating factor corresponds to TopBP1.
In conclusion, these studies have provided the first con-
crete mechanistic insight into how ATR undergoes activa-
tion during checkpoint responses. Further study of this
process should advance understanding of how eukaryotic
cells preserve their genomes.
EXPERIMENTAL PROCEDURES
Xenopus Egg Extracts
Extracts from Xenopus eggs were prepared as described (Kumagai
and Dunphy, 2000). A DNA replication checkpoint response was in-
duced by addition of 50 mg/ml aphidicolin into extracts containing
demembranated sperm nuclei (3000 per ml) (Kumagai and Dunphy,
2000). To monitor DNA replication, extracts containing 1000 sperm
nuclei/ml were incubated with [a-32P]dATP (Yoo et al., 2004).
Antibodies
Antibodies against Xatr, Xatrip, Xatm, Xchk1, anti-phospho-S344 of
Xchk1, and anti-phospho-S92 of Xmcm2 were described previously
(Kumagai et al., 2004; Yoo et al., 2004). Anti-XtopBP1 antibodies
were prepared as described (Van Hatten et al., 2002). Anti-FLAG,
anti-Myc, anti-human Chk1 (G-4), anti-humanMcm2 (BM28), and con-
trol rabbit antibodies (IgG fraction) were purchased from Sigma, Cal-
biochem, Santa Cruz Biotechnology, BD Transduction Laboratories,
and Zymed, respectively.
Recombinant Proteins
Full-length Xatrip-FLAG and XatripDN222-FLAG with His6 and FLAG
tags at the N-terminal and C-terminal ends, respectively, were pro-
duced in baculovirus-infected Sf9 insect cells (Kumagai et al., 2004;
Kim et al., 2005). Full-length XtopBP1, XtopBP1D993-1196, and
XtopBP1-W1138R with a His6 tag at their N-terminal ends wereCell 124, 943–955, March 10, 2006 ª2006 Elsevier Inc. 953
purified from Sf9 cells by the same procedure and dialyzed against 10
mM HEPES-KOH (pH 7.5), 80 mM NaCl, and 1 mM dithiothreitol. Full-
length Xchk1 with Myc and His6 tags at the C-terminal end was also
produced in Sf9 cells. GST fusion proteins containing fragments of
XtopBP1 and human TopBP1 were produced in Escherichia coli
BL21 CodonPlus RIL cells. Mutant DNA constructs were prepared
with the QuikChange Site-Directed Mutagenesis Kit (Stratagene).
Isolation of Xatr-Xatrip Complexes from Egg Extracts
Xatrip-FLAG and XatripDN222-FLAG (20 ng/ml each) were incubated in
interphase extracts containing anti-FLAG M2 antibody beads (Sigma)
for 60 min at room temperature. The beads were isolated and washed
twice with buffer A (10 mM HEPES-KOH [pH 7.5], 150 mM NaCl, 0.1%
CHAPS, and 2.5 mM EGTA) and twice with HEPES-buffered saline
(HBS; 10 mM HEPES-KOH [pH 7.5] and 150 mM NaCl). Xatr-Xatrip
complexes were eluted in one-tenth the volume of the egg extract in
HBS containing 0.1 mg/ml 3X-FLAG peptide (Sigma) for 60 min at
4ºC. Eluates (2 ml) were used for kinase assays as described below.
Kinase Assays
Samples were incubated in 20 ml kinase buffer (50 mM Tris-HCl [pH
7.5], 10 mM MgCl2, 1 mM dithiothreitol, 100 mM nonradioactive ATP,
and 100 mCi/ml [g-32P]ATP) containing 12.5 mg/ml PHAS-I or 50 mg/
ml GST-Xmcm2(62–122) for 30 min at room temperature. GST-
XtopBP1(972–1279) was added at a final concentration of 100 mg/ml
unless indicated otherwise. In some cases, GST-Xmcm2(62–122),
GST-Xchk1(306–352), or full-length Xchk1-Myc-His6 was used as a
substrate with only 1 mM nonradioactive ATP. Reactions were termi-
nated by boiling in gel sample buffer.
Immunodepletion from Egg Extracts
Xatr and Xatrip were immunodepleted as described (Kumagai et al.,
2004). For immunodepletion of XtopBP1, we incubated 100 ml egg ex-
tract twice for 60minwith 10 ml Affiprep protein A beads (Bio-Rad) con-
taining 35 mg of anti-XtopBP1 antibodies.
Preparation of Recombinant Wild-Type
and Kinase-Deficient Human FLAG-ATR
U2OS cells conditionally expressing wild-type (GW33) or kinase-defi-
cient (GK41) human FLAG-ATR were cultured as described (Nghiem
et al., 2001). Cells were induced with 1 mg/ml doxycycline for 48 hr. Nu-
clear extracts were prepared as described (Dignam et al., 1983) except
that nuclei were lysed by brief sonication and the concentration of
NaCl in the nuclear isolation buffer was reduced to 350 mM in order
to preserve the binding of endogenous ATRIP to recombinant ATR.
FLAG-ATR proteins were isolated by an overnight incubation with
anti-FLAG antibodies bound to protein G magnetic beads (Dynal)
and eluted with 3X-FLAG peptide.
Expression of Human TopBP1 Fragments in Tissue Culture Cells
pEGFP-NLS-TopBP1(978–1286), which encodes EGFP followed by
a nuclear localization sequence (KKKRKV) and amino acids 978–
1286 of human TopBP1, was prepared from pEGFP (Clontech) by
standard polymerase-chain-reaction-based methods. Plasmids were
transfected into 293T cells with Lipofectamine 2000 (Invitrogen).
Supplemental Data
Supplemental Data include two figures and can be found with this arti-
cle online at http://www.cell.com/cgi/content/full/124/5/943/DC1/.
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